ALPS Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-55,033
| Closed | -$87.5K | – | 1062 |
|
|
2025
Q1 | $87.5K | Sell |
55,033
-2,554
| -4% | -$4.06K | ﹤0.01% | 982 |
|
|
2024
Q4 | $174K | Buy |
57,587
+1,371
| +2% | +$4.15K | ﹤0.01% | 975 |
|
|
2024
Q3 | $207K | Buy |
56,216
+802
| +1% | +$2.95K | ﹤0.01% | 978 |
|
|
2024
Q2 | $227K | Buy |
55,414
+5,360
| +11% | +$21.9K | ﹤0.01% | 942 |
|
|
2024
Q1 | $789K | Buy |
50,054
+2,147
| +4% | +$33.8K | 0.01% | 534 |
|
|
2023
Q4 | $726K | Sell |
47,907
-4,218
| -8% | -$63.9K | 0.01% | 553 |
|
|
2023
Q3 | $1.05M | Buy |
52,125
+8,407
| +19% | +$169K | 0.01% | 431 |
|
|
2023
Q2 | $1.23M | Buy |
+43,718
| New | +$1.23M | 0.01% | 420 |
|